Finance

Lists
R1MD34:BVMF
Resmed Inc Bdr
R$ 243.85
+0.23%
(+0.57) 1D
7-р сарын 23, 11:58:35 (GMT-3)  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for R1MD34...
Mkt. cap
33.03 тэрбум
Avg. vol.
0.00
Volume
0.00
52-wk high
R$ 373.88
52-wk low
R$ 242.17
Shares outstanding
140.64 сая
No. of employees
11 мян
Mkt. cap
33.03 тэрбум
Avg. vol.
0.00
Volume
0.00
52-wk high
R$ 373.88
52-wk low
R$ 242.17
Shares outstanding
140.64 сая
No. of employees
11 мян
News stories
From web sources and news partners
Benzinga
Benzinga
·
7 цагийн өмнө
ResMed Q4 2026 Earnings Call Transcript
Investing.com Nigeria
Investing.com Nigeria
·
1 өдрийн өмнө
Form 144 RESMED INC For: 10 October By Investing.com
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc Bdr
CEOMichael J. Farrell
Employees11.4 мян
Founded6-р сар 1989
HeadquartersСан-Диего, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websiteresmed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.34 тэрбум
1.42 тэрбум
1.43 тэрбум
1.46 тэрбум
Cost of goods sold
506.94 сая
536.28 сая
532.58 сая
594.13 сая
Cost of revenue
506.94 сая
536.28 сая
532.58 сая
594.13 сая
Research and development expenses
87.32 сая
90.97 сая
94.27 сая
105.72 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259.19 сая
275.70 сая
279.80 сая
293.36 сая
Operating expense
366.29 сая
386.24 сая
393.16 сая
417.88 сая
Total operating expenses
873.24 сая
922.51 сая
925.74 сая
1.01 тэрбум
Operating income
462.35 сая
500.30 сая
505.67 сая
451.64 сая
Other non operating income
-3.84 сая
42.00 мян
181.00 мян
4.40 сая
EBT including unusual items
446.79 сая
496.15 сая
502.31 сая
474.16 сая
EBT excluding unusual items
468.79 сая
504.48 сая
518.30 сая
476.09 сая
Income tax expense
98.26 сая
103.56 сая
103.58 сая
90.73 сая
Effective tax rate
21.99%
20.87%
20.62%
19.14%
Other operating expenses
-
-
-
-
Net income
348.54 сая
392.59 сая
398.73 сая
383.43 сая
Net profit margin
26.10%
27.59%
27.86%
26.20%
Earnings per share
2.55
2.81
0.29
0.30
Interest and investment income
4.69 сая
4.46 сая
3.80 сая
31.76 сая
Interest expense
-
-
-
-
Net interest expenses
4.69 сая
4.46 сая
3.80 сая
31.76 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
503.64 сая
543.79 сая
558.22 сая
490.13 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс